83 /100
CRITICAL RISK
Score updated May 29, 2026

NTHI — NeOnc Technologies Holdings, Inc. Dilution Risk Tracker

Track NTHI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NTHI — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
95
📊 Float Risk
70
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌩️
Severe
Multiple high-probability dilution events detected
63%
💰 Capital Raise 93%
• Critical: only 1.0 months cash remaining
• Active shelf registration ($300M, 241% of market cap)
📉 Score Deterioration 55%
• Score rose 56 points recently (worsening)
• Score already CRITICAL (83/100) — events likely imminent
🔔 Track NTHI — Get forecast alerts →

💹 Market Data

Market Cap$124.60M
Shares Outstanding26.01M
Float7.99M
Cash$138.6K
Debt$346.1K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 28.8% shares (2025Q4 vs prior)
23 institutional holders · 2.36M shares
#1 HighPoint Advisor Group LLC 1.14M shares
#2 BANK OF AMERICA CORP /DE/ 450.8K shares
#3 VANGUARD GROUP INC 181.0K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest274.8K
Days to Cover3.9
% of Float3.4%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 31, 2024
424B5 ATM Apr 16, 2026
EFFECT EFFECT Apr 16, 2026
3 FORM3 Apr 13, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track NTHI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NTHI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for NTHI
📊 NTHI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NTHI Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.